Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Doctor training aims to cut risky pill overload in seniors

NCT ID NCT06470308

Knowledge-focused Sponsor: University of Crete Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving general practitioners special training on how to safely reduce unnecessary medications can improve prescribing for older adults. About 200 patients aged 65 and older who take at least five medications will be enrolled. Their doctors will either receive the training or provide usual care, and researchers will compare changes in medication use and safety.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
educational intervention for general practitioners on deprescribing
What this could lead to
If successful, this could show that training doctors to review and reduce medications improves safety for older adults on many drugs.
What could go wrong
This is a relatively small, early-stage study in one country. The intervention may not change prescribing habits or reduce harms in the long term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * community-dwelling patients * Age ≥ 65 years * Receive at least 5 medication ( polypharmacy ) Exclusion Criteria: * hospitalized or patients living in nursing home * Incapable of giving written consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Deprescriptions are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Frailty Prescription Drug Overuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Deprescriptions Frailty syndrome Medication overuse Polypharmacy

Contacts and locations

Locations

  • Primary Care Facilities

    Heraklion, Heraklion, Crete, 71303, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.